Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMBROSIA: Ambroxol Lozenges in Adolescents with Sore Throat
NCT00144274Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2005
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in acute viral pharyngitis, sponsored by Boehringer Ingelheim. Started Apr 2005; status: completed.
02
Drugs
ambroxol
03
Conditions
acute viral pharyngitis
Beyond the preview
Go deeper on NCT00144274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144274.